005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 11,580.00
−0.43%Forward multiples
Based on analyst estimates
- P/E forward
- 22.71x
- P/E 2026E
- 12.70x
- P/E 2027E
- 10.26x
- P/E 2028E
- —
- P/S forward
- 8.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.93x
- PEG TTM
- 0.32x
- Price / book
- 4.85x
- Price / sales
- 5.11x
- Price / cash flow
- 16.94x
Enterprise value
- Enterprise value
- KRW 654.7B
- EV / sales
- 4.82x
- EV / EBITDA
- 13.93x
- EV / EBIT
- 14.87x
- Market cap
- KRW 694.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026